Ekaterina E. Bykova

Ekaterina E. Bykova

Auto-generated profile, based on publicly available information

Ekaterina E. Bykova

I.M. Sechenov First Moscow State Medical University

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2021 in Rational Pharmacotherapy in Cardiology
Verified
Journal Article
Open access
PDF file
VPV. I. Podzolkov
V. I. Podzolkov
ABAnna E. Bragina
Anna E. Bragina
ATA. I. Tarzimanova
A. I. Tarzimanova
LVL. V. Vasil'EVa
L. V. Vasil'EVa
Elena BatrakovaElena Batrakova
Elena Batrakova
MKM. M. Khachuroeva
M. M. Khachuroeva
The coronavirus pandemic showed not only an increase in levels of excess morbidity and mortality in the acute phase, but also persisting symptoms 4 weeks after the onset of the disease. A review of international studies on the prevalence and diversity of the manifestations of postcoid syndrome is presented. The data on such a manifestation of post-COVID syndrome as postural orthostatic tachycardia syndrome (POTS) are accumulating. Pathogenetic mechanisms, modern diagnostic criteria and research data on the prevalence of this syndrome are presented in the article. The Canadian Cardiovascular Society has proposed medications as a treatment for POTS, including the sinus node If channel inhibitor ivabradine. Data from several studies showing the effectiveness of this drug for POTS, including after suffering COVID-19, are presented in the article. Clinical data on the prevalence of tachycardia among patients admitted to the Sechenov University hospital are presented. About 18% of patients with hypertension and 21% of patients with normal blood pressure had a high heart rate. A clinical example of the use of ivabradine in a patient after a coronavirus infection is presented. Drug interactions and individual tolerance of ivabradine in patients after coronavirus infection are being discussed. The authors put forward the hypothesis about the further prospect of using ivabradine in the treatment of clinical manifestations of postcoid syndrome on the basis of literature data and their own experience.

6 March 2023 in Rational Pharmacotherapy in Cardiology
Verified
Journal Article
Open access
PDF file
VPV. I. Podzolkov
V. I. Podzolkov
ABAnna E. Bragina
Anna E. Bragina
ATA. I. Tarzimanova
A. I. Tarzimanova
LVL. V. Vasilyeva
L. V. Vasilyeva
EOE. S. Ogibenina
E. S. Ogibenina
NDNatalya Druzhinina
Natalya Druzhinina
Aim. To assess the association of hypertension with the severe forms and fatal outcomes of Coronavirus disease 2019 (COVID-19).Material and Methods. This retrospective cohort study involved adult patients (≥18 years old), admitted to the University hospital №4 of Sechenov University (Moscow, Russia) between 08 April 2020 and 19 November 2020 with clinically diagnosed or laboratory-confirmed COVID-19. The cohort included 1637 patients. The primary outcome was all-cause in-hospital mortality. The secondary outcomes included intensive care unit admission (ICU) and invasive ventilation. Multiple logistic regression was performed to assess the independent association between risk factors and endpoints.Results. A total of 1637 patients were included in the study. 51.80% (n=848) of the subjects were males. The median age was 59.0 (48.0; 70.0) years and 55.90% (n=915) had pre-existing diagnosis of hypertension. Patients with hypertension had significantly more severe lung injury based on chest CT scan findings as well as lower oxygen saturation (SрO2). More of them were admitted to ICU and placed on invasive ventilation. The hypertension group also had higher mortality. Age, hypertension, glucose, C-reactive protein and decreased platelet count were independently associated with mortality, hypertension having the strongest association (OR 1.827, 95% CI 1.174-2.846, p=0.008). Age, hypertension, neutrophil count, platelet count, glucose, and CRP were independently associated with ICU admission, with hypertension having the strongest association (OR 1.595, 95% CI 1.178-2.158, p=0.002). Age, hypertension, glucose, CRP and decreased platelet count were independently associated with invasive ventilation, with hypertension having the strongest association (OR 1.703, 95% CI 1.151-2.519, p=0.008).Based on the multiple logistic regression models, odds of death, ICU admission, and invasive ventilation were higher in the hypertension group as compared to the group without hypertension.Conclusion. Hypertension can be an independent predictor of severe COVID-19 and adverse outcomes, namely death, ICU admission, and invasive ventilation in hospitalized patients.

12 January 2022 in Rational Pharmacotherapy in Cardiology
Verified
Journal Article
Open access
PDF file
VPV. I. Podzolkov
V. I. Podzolkov
ATA. I. Tarzimanova
A. I. Tarzimanova
ABAnna E. Bragina
Anna E. Bragina
ISI. I. Shvedov
I. I. Shvedov
EBE. E. Bykova
E. E. Bykova
LVL. V. Vasilyeva
L. V. Vasilyeva
Aim. To evaluate the effect of sinus tachycardia and reduced left ventricular ejection fraction (LVEF) on the prognosis of patients with a verified diagnosis of a new coronavirus infection SARS-CoV-2.Material and methods. The study included 1,637 patients with a verified diagnosis of a new coronavirus infection SARS-CoV-2. The average age of the patients was 58.8±16.1 years. More than half of the patients admitted to the hospital had a history of cardiovascular diseases: hypertension was diagnosed in 915 (56%) patients, coronary artery disease – in 563 (34%), chronic heart failure – in 410 (25%). 294 (17.9%) patients suffered from diabetes mellitus. The unfavorable course of new coronavirus infection was assessed by the fact of being in the intensive care unit (ICU), the use of mechanical ventilation and death.Results. An unfavorable course of coronavirus infection was observed in 160 (9.8%) patients. Statistical analysis revealed that 341 (20.8%) patients with COVID-19 were diagnosed with sinus tachycardia, which required the appointment of pulse-reducing therapy. The occurrence of sinus tachycardia in patients with COVID-19 significantly increased the risk of death (odds ratio [OR] 1.248, confidence interval [CI] 1.038-1.499, p=0.018), increased the likelihood of mechanical ventilation use (OR 1.451, CI 1.168-1.803, p<0.001) and stay in the ICU (OR 1.440, CI 1.166-1.778, p<0.001).In 97 (5.9%) patients during hospital stay during echocardiography, a decrease in LVEF of less than 50% was diagnosed. A decrease in myocardial contractile function in patients with COVID-19 with high reliability increased the risk of death (OR 1.744, CI 1.348-2.256, p<0.001), increased the likelihood of using the mechanical ventilation (OR 1.372, CI 1.047-1.797, p=0.022) and stay in the ICU (OR 1.360, CI 1.077-1.716, p=0.010).Conclusion. The appearance of sinus tachycardia and reduced LVEF are in dependent predictors of the unfavorable course of COVID-19 in relation to factors such as death, the use of mechanical ventilation and the stay of patients in the ICU. Early pharmacological correction of cardiovascular lesions should be one of the goals of the management theese patients.

30 September 2019 in Integration of Education
Verified
Journal Article
Open access
MVMaria V. Vetluzhskaya
Maria V. Vetluzhskaya
AAAntonina A. Abramova
Antonina A. Abramova
KSKira G. Serdakova
Kira G. Serdakova
EBEkaterina E. Bykova
Ekaterina E. Bykova
RKRina S. Khammatova
Rina S. Khammatova
RSRaisa V. Shurupova
Raisa V. Shurupova
Introduction. The article presents the results of a study, whose purpose was to investigate emotional intelligence and empathic abilities as well as to identify correlations between these indicators in 3rd year medical school students. The relevance of the work is determined by the fact that both empathy and emotional intelligence play an important role in the formation of the professional competencies of future doctors. Materials and Methods. The study was based around a survey of 92 students of the Sechenov University. Data gathering was carried out using the Assessment of the Level of Empathic Abilities by V.V. Boiko and The Emotional Intelligence Test by N. Hall. The relationship between emotional intelligence and empathic abilities was studied. Data were analysed using STATISTICA 8.0. Results. The majority of the participants were found to have both an understated and a very low level of empathic capability. The least developed were the intuitive, rational and emotional components, while the most developed was the “installations that promote empathy” component. The majority of the participants had a low level of emotional intelligence in Hall’s terms, with the worst developed parameters seen to be “managing your emotions” and “self-motivation”. The most developed parameter was “emotional awareness”. The results showed an average positive correlation between Hall’s empathy and the total indicator of empathic abilities (r = 0.37, p < 0.01), the intuitive channel (r = 0.32, p < 0.01), the “empathy facilities” (r = 0.31, p < 0.01) and the “empathy identification” (r = 0.26, p = 0.01) , as well as between “recognition other people’s emotions” and the total indicator of empathic abilities (r = 0.28, p < 0.05). The study found an average negative correlation between the “managing your emotions” and the “emotional channel” (r = -0.41, p < 0.001), the “rational channel” (r = -0.31, p = 0.003), the total indicator of empathic abilities (r = -0.28, p < 0.05). Discussion and Conclusion. Most of the participants have a low level of empathic abilities and emotional intelligence. The results of the study identify the need to develop empathic abilities and emotional intelligence in medical students with a focus on intuitive, rational and emotional channels of empathy, as well as “managing your emotions” and “self-motivation”, in order to train communicative professional competencies during the course of higher education.

9 August 2022 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
VPV. I. Podzolkov
V. I. Podzolkov
ATA. I. Tarzimanova
A. I. Tarzimanova
ABAnna E. Bragina
Anna E. Bragina
ILIrakli Loriya
Irakli Loriya
APA. E. Pokrovskaya
A. E. Pokrovskaya
DVD. D. Vanina
D. D. Vanina
Early diagnosis of atrial fibrillation (AF) predictors in coronavirus disease 2019 (COVID-19) and the appointment of additional therapy to prevent arrhythmias will improve the prognosis of patients.Aim. To identify predictors of AF in patients with COVID-19.Material and methods. This retrospective study included 1473 patients hospitalized with COVID-19. Depending on AF occurrence, the patients were divided into 2 groups as follows: group I included 95 patients with AF episodes during hospitalization; group II consisted of 1378 patients who did not have AF during hospitalization. All patients underwent a complete blood count and urine tests, a biochemical and coagulation blood tests, 12-lead electrocardiography, chest computed tomography (CT), and echocardiography.Results. Chest CT found that lung tissue involvement in patients of group I was significantly greater than in group II (p50% (CT-3 and CT-4) was significantly higher in the AF group than in the control group. The average room air oxygen saturation upon admission to the hospital were significantly lower in patients with AF than in the comparison group (p60 years, hypertension, coronary artery disease, heart failure, increased left atrial volume, large lung tissue involvement, and increased interleukin- 6 level.Conclusion. There are two following groups of predictors initiating AF in COVID-19: generally known (older age, cardiovascular disease, increased left atrial volume) and those that determine the severe COVID-19 course (large lung damage and high interleukin-6 levels).

22 December 2023 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
PDF file
VPValery I. Podzolkov
Valery I. Podzolkov
EVElena V. Volchkova
Elena V. Volchkova
ATAida I. Tarzimanova
Aida I. Tarzimanova
ABAnna E. Bragina
Anna E. Bragina
AIAlexander Ivannikov
Alexander Ivannikov
AIAlena Y. Isaeva
Alena Y. Isaeva
Aim. To identify predictors of the development of thromboembolic complications (TECs) in patients with severe SARS-CoV-2 coronavirus infection.Materials and methods. A single-center observational retrospective study included 1634 patients with a confirmed diagnosis of SARS-CoV-2 coronavirus infection. The patients were divided into 2 groups depending on the availability of the feasibility study. The criterion for inclusion of patients in the main group was the presence of venous feasibility studies in 127 patients (group I), the comparison group consisted of 1507 patients in whom the course of COVID-19 was not complicated by the development of feasibility studies (group II).Results. When performing computed tomography of the chest organs, it was revealed that patients with a feasibility study had a higher percentage of lung tissue damage than patients in the comparison group: 55% [37.5; 67.5] and 37.5% [25.0; 47.5], respectively (p0.001). The average values of C-reactive protein in I patients group were 129 [60.1; 211] ng/l, which was significantly higher than in II patients group – 41.0 [12.2; 97.6] ng/l (p0.001), interleukin-6 – 176 [52.9; 471] pg/ml and 39.4 [11.0; 107] pg/ml (p0.001), respectively. A one-factor regression analysis proved a significant contribution of comorbid pathology to the development of feasibility studies in patients with COVID-19. The presence of three nosologies at the same time: arterial hypertension, coronary heart disease (CHD) and chronic kidney disease increased the probability of a feasibility study by 4.81 times (odds ratio 4.8117, 95% confidence interval 3.2064–7.2207), in patients with arterial hypertension, CHD, chronic kidney disease and type 2 diabetes – by 5.63 times (odds ratio 5.6321, 95% confidence interval 3.1870–9.9531).Conclusion. The presence of severe comorbid pathology significantly increased the risk of developing a feasibility study in patients with COVID-19. The most significant predictors of the development of feasibility studies in patients with severe SARS-CoV-2 coronavirus infection. They are: CHD, arterial hypertension and type 2 diabetes.